A study presented at the American Urological Association’s 2014 annual meeting in Orlando suggests that a planned follow-up of at least 15 years after prostate cancer (PCa) treatment is a reasonable approach to monitor for late recurrence.

The study included more than 2,800 PCa patients who underwent radiotherapy. Of these, 48 experienced late recurrence, that is, recurrence more than 10 years after treatment. The late recurrence rate at 10, 15, and 20 years was 0%, 3%, and 5%.

Renal & Urology News would like to ask urologists the following poll question. All responses are anonymous.

Continue Reading